Literature DB >> 26587456

Key Points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014.

Kazuomi Kario1.   

Abstract

The Japanese Society of Hypertension (JSH) published the new JSH guidelines for the management of hypertension in 2014, which is the revision of the JSH guidelines of 2009. The primary objective of the guideline is to provide physicians the standard treatment strategy of hypertension to prevent the hypertension-related target organ damage and cardiovascular events. The management of hypertension should be performed in hypertensive patients with a blood pressure of ≥140/90 mm Hg. As Asians have a higher prevalence of stroke than of coronary artery disease and stroke is more steeply associated with the level of blood pressure, the target blood pressure should be lower than 130/80 mm Hg for high-risk patients such as those with diabetes or chronic kidney disease. Because of the increasing prevalence of obesity and the related metabolic syndrome, more salt intake and higher salt sensitivity in the population, lifestyle modifications are necessary in hypertensive patients and subjects with high normal blood pressure. This guideline provides evidence-based recommendations for the management of patients with hypertension with the characteristics of our society.

Entities:  

Keywords:  Guideline; Hypertension; Japanese

Year:  2015        PMID: 26587456      PMCID: PMC4646136          DOI: 10.1159/000381300

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  37 in total

1.  Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan.

Authors: 
Journal:  Blood Press Monit       Date:  1996-06       Impact factor: 1.444

Review 2.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

3.  Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.

Authors:  Toshio Ogihara; Masunori Matsuzaki; Seiji Umemoto; Hiromi Rakugi; Hiroaki Matsuoka; Kazuyuki Shimada; Jitsuo Higaki; Sadayoshi Ito; Akira Kamiya; Hiromichi Suzuki; Yasuo Ohashi; Kazuaki Shimamoto; Takao Saruta
Journal:  Hypertens Res       Date:  2012-01-26       Impact factor: 3.872

Review 4.  Prognosis in relation to blood pressure variability: pro side of the argument.

Authors:  Kazuomi Kario
Journal:  Hypertension       Date:  2015-04-27       Impact factor: 10.190

Review 5.  [Scientific statement] Report of the Salt Reduction Committee of the Japanese Society of Hypertension (3) Assessment and application of salt intake in the management of hypertension.

Authors:  Takuya Tsuchihashi; Hisashi Kai; Miho Kusaka; Minoru Kawamura; Hideo Matsuura; Katsuyuki Miura; Katsuyuki Ando; Satomi Maruyama; Hitomi Hayabuchi; Yoko Takagi; Norie Nakahigashi; Toshiko Sato; Yuhei Kawano
Journal:  Hypertens Res       Date:  2013-10-24       Impact factor: 3.872

6.  Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.

Authors:  Kei Asayama; Takayoshi Ohkubo; Hirohito Metoki; Taku Obara; Ryusuke Inoue; Masahiro Kikuya; Lutgarde Thijs; Jan A Staessen; Yutaka Imai
Journal:  Hypertens Res       Date:  2012-08-16       Impact factor: 3.872

7.  Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study.

Authors:  Hirohito Metoki; Takayoshi Ohkubo; Masahiro Kikuya; Kei Asayama; Taku Obara; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Hiroshi Satoh; Yutaka Imai
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

8.  Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers.

Authors:  K Kario; T Matsuo; H Kobayashi; M Imiya; M Matsuo; K Shimada
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

9.  Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study.

Authors:  Satoshi Hoshide; Kazuomi Kario; Yuichiro Yano; Hajime Haimoto; Kayo Yamagiwa; Kiyoshi Uchiba; Shoichiro Nagasaka; Yoshio Matsui; Akira Nakamura; Motoki Fukutomi; Kazuo Eguchi; Joji Ishikawa
Journal:  Am J Hypertens       Date:  2014-01-28       Impact factor: 2.689

10.  Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Shizukiyo Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-18       Impact factor: 3.738

View more
  11 in total

1.  Hypertension Guidelines: Timely New Initiatives from East Asia.

Authors:  John Chalmers
Journal:  Pulse (Basel)       Date:  2015-04-29

2.  Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.

Authors:  Toshiyuki Tahara; Kiyoto Mori; Mari Mochizuki; Ryoko Ishiyama; Marin Noda; Hitomi Hoshi; Alan Kawarai Lefor; Satoshi Shinozaki
Journal:  Biomed Rep       Date:  2017-10-23

Review 3.  Impact of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines on the Next Blood Pressure Guidelines in Asia.

Authors:  Naoki Nakagawa; Naoyuki Hasebe
Journal:  Curr Hypertens Rep       Date:  2019-01-10       Impact factor: 5.369

4.  Appearance and potential predictors of poorly controlled hypertension at the primary care level in an urban community.

Authors:  Sawitree Visanuyothin; Samlee Plianbangchang; Ratana Somrongthong
Journal:  J Multidiscip Healthc       Date:  2018-02-23

5.  Effects of a dietary supplement on inflammatory marker expression in middle-aged and elderly hypertensive patients.

Authors:  Jia Wang; Zhongxin Hong; Nan Wang; Li Wu; Bingjie Ding; Zhiwen Ge; Yanxia Bi; Wei Li
Journal:  Clinics (Sao Paulo)       Date:  2019-04-08       Impact factor: 2.365

6.  Relationship between non-communicable diseases and background characteristics among homeless people in Nagoya City, Japan.

Authors:  Akihiro Nishio; Ryo Horita; Tadahiro Sado; Takahiro Watanabe; Ryosuke Uehara; Seiko Mizutani; Mayumi Yamamoto
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

7.  Age group differences in association between IADL decline and depressive symptoms in community-dwelling elderly.

Authors:  Eri Kiyoshige; Mai Kabayama; Yasuyuki Gondo; Yukie Masui; Hiroki Inagaki; Madoka Ogawa; Takeshi Nakagawa; Saori Yasumoto; Hiroshi Akasaka; Ken Sugimoto; Kazunori Ikebe; Yasumichi Arai; Tatsuro Ishizaki; Hiromi Rakugi; Kei Kamide
Journal:  BMC Geriatr       Date:  2019-11-13       Impact factor: 3.921

8.  Physician and patient perspectives on hypertension management and factors associated with lifestyle modifications in Japan: results from an online survey.

Authors:  Nobuhiro Nishigaki; Yukio Shimasaki; Takuo Yoshida; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2020-01-29       Impact factor: 3.872

9.  The effect of alcohol dose on the development of hypertension in Asian and Western men: systematic review and meta-analysis.

Authors:  Mi-Hyang Jung; Ein-Soon Shin; Sang-Hyun Ihm; Jin-Gyu Jung; Hae-Young Lee; Cheol-Ho Kim
Journal:  Korean J Intern Med       Date:  2019-12-06       Impact factor: 2.884

10.  Prevalence and Correlates of Hypertension among Japanese Adults, 1975 to 2010.

Authors:  Katharina Otani; Rei Haruyama; Stuart Gilmour
Journal:  Int J Environ Res Public Health       Date:  2018-08-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.